MULTIPHARMA GROUP
ActiveSummary
MULTIPHARMA GROUP has been active since 1912 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €164.7m and a net result of -€242,114. Equity is growing by about 18% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.1% (very low).
Directors
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| Bart BECKS |
|
| Jean Paul PHILIPPOT |
|
| Lieven MEERT |
|
| Mieke VANMARCKE |
|
| Sarah WILLOCKX |
|
Owners and capital
Owners
22 ownersOwners 22
-
10%
-
10%
-
9.9%
- 9.9%
-
9.9%
-
9.9%
-
9.9%
-
9.5%
- Sourceown accounts 20255.4%
-
3.8%
Show 12 more owners
-
3.7%
-
3.3%
-
2.3%
-
0.9%
-
0.5%
-
0.4%
-
0.3%
-
0.2%
-
0.1%
-
0.1%
-
0.1%
-
2 shares
According to the 2025 annual accounts of MULTIPHARMA GROUP and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.